drugset / Trial / NCT03092154
Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis
RandomizedParallel-groupTriple-blindTreatment
Summary
The use of lipid lowering agents in patients with idiopathic inflammatory myopathies is controversial. Therefore, the aim of the present study is to assess clinically and laboratory the impact of lipid-lowering agents in this population.
Timeline
- Start
- 2017-01
- Primary completion
- 2022-05-31
- Completion
- 2022-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artovastatin | Unknown | 20 mg | Oral |
Indications
No indication recorded.